SecBot SecBot
SC TO-I/A ·Filed Oct 8, 2026

MDT

Medtronic plc
NEUTRAL
Impact 6/10
Horizondays Processed19d 15h ago SEC0001628280-26-065406
Notable filing: SC TO-I/A
Actionable Insight • Neutral

Watch for the final results of the exchange offer results due after October 9, 2026. The proration will determine the final share count reduction. The exchange is a structural event, not a fundamental change.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+5d ⚠ clustered
MDT ▲ +8.77% at T+5d
NEUTRAL call +8.77% · α vs SPY +9.05% · entry $87.75 → $95.45
Next anchor: T+20d in 8d
Latest observation: T+11 +1.76% FF3 residual α
Entry = T+0 close
Oct 8, 2026
via day close
T+1d
+0.83%
call +0.83% · α +0.23%
$88.48
settled 19d ago
T+5d
+8.77%
call +8.77% · α +9.05%
$95.45
settled 13d ago
T+20d
Pending
in 8d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

Medtronic filed Amendment No. 2 to its Schedule TO, setting the final exchange ratio at 4.5939 MiniMed shares per Medtronic ordinary share in its split-off of MiniMed Group. The exchange offer expires October 9, 2026, and Medtronic will accept up to ~55 million Medtronic shares if oversubscribed, representing a significant reduction in Medtronic's share count and full exit from its MiniMed stake.

Key Facts

  • Final exchange ratio set at 4.5939 MiniMed shares per Medtronic ordinary share.
  • Medtronic offering up to 225,361,295 MiniMed shares (80.1% of outstanding MiniMed stock).
  • If oversubscribed, Medtronic may exchange additional 27,452,053 MiniMed shares for up to ~5,975,762 Medtronic shares (De Minimis Increase).
  • Medtronic would accept ~55,032,401 Medtronic shares if oversubscribed, or ~49,056,639 if not.
  • Exchange offer expires at midnight October 9, 2026.
  • Goldman Sachs and BofA Securities are dealer managers.

Financial Impact

Medtronic will exchange up to ~55 million Medtronic shares for MiniMed shares, reducing Medtronic's share count by up to ~55 million shares (if oversubscribed). The exchange ratio was set at the upper limit of 4.5939, with no cash involved.

dilutionshare countdebtdebt

Risk Factors

  • Oversubscription may be oversubscribed, leading to proration and potential lower share reduction.
  • The exchange is a structural event, not a fundamental change.

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
SC TO-I/A Filing (Primary)0001628280-26-065406
Document: 0001628280-26-065406-index-headers.html0001628280-26-065406
Document: 0001628280-26-065406-index.html0001628280-26-065406
Document: 0001628280-26-065406.txt0001628280-26-065406
50 reports for MDT
Performance horizon
100% Hit rate @ T+60 5 of 5 directional calls Went positive at some point 10 of 12 best @ T+60▲ +15.30%Jun 3, 2026
Filters
Rows
Reports for MDT — sortable, filterable
TypeNow
Oct 19, 2026
8d ago
8-K
NEUTRAL ★ 4/10
$94.63awaiting T+60—$93.95 (−0.72%)
Oct 16, 2026
11d ago
Insider Cluster
BEARISH ★ 5/10
$92.77awaiting T+60—$93.95 (−1.27%)
Oct 16, 2026
11d ago
Insider Cluster
BEARISH ★ 5/10
$92.77awaiting T+60—$93.95 (−1.27%)
Oct 15, 2026
12d ago
144
NEUTRAL ★ 3/10
$95.45awaiting T+60—$93.95 (−1.57%)
Oct 14, 2026
13d ago
SC TO-I/A
NEUTRAL ★ 5/10
$94.23awaiting T+60—$93.95 (−0.30%)
Oct 14, 2026
13d ago
425
NEUTRAL ★ 5/10
$94.23awaiting T+60—$93.95 (−0.30%)
Oct 13, 2026
14d ago
SC TO-I/A
NEUTRAL ★ 5/10
$93.01awaiting T+60—$93.95 (+1.01%)
Oct 13, 2026
14d ago
425
NEUTRAL ★ 5/10
$93.01awaiting T+60—$93.95 (+1.01%)
Oct 9, 2026
18d ago
425
NEUTRAL ★ 3/10
$91.93awaiting T+60—$93.95 (+2.20%)
Oct 8, 2026
19d ago
425
NEUTRAL ★ 3/10
$88.48awaiting T+60—$93.95 (+6.18%)
Showing 10 of 50

US Market Status

Market Closed — Opens Thu (9h 58m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 8, 2026